COVID-19 pandemic effects on breast cancer diagnosis in Croatia: A population-and registry-based study E Vrdoljak, MP Balja, Z Marušić, M Avirović, V Blažičević, Č Tomasović, ... The oncologist 26 (7), e1156-e1160, 2021 | 46 | 2021 |
Osteopontin is associated with decreased apoptosis and αv integrin expression in lung adenocarcinoma C Štemberger, K Matušan-Ilijaš, M Avirović, L Bulat-Kardum, A Ivančić, ... Acta histochemica 116 (1), 222-229, 2014 | 29 | 2014 |
EGFR expression is linked to osteopontin and Nf-κB signaling in clear cell renal cell carcinoma K Matušan-Ilijaš, G Damante, D Fabbro, G Đorđević, I Hadžisejdić, ... Clinical and Translational Oncology 15, 65-71, 2013 | 29 | 2013 |
Applying explainable machine learning models for detection of breast cancer lymph node metastasis in patients eligible for neoadjuvant treatment J Vrdoljak, Z Boban, D Barić, D Šegvić, M Kumrić, M Avirović, ... Cancers 15 (3), 634, 2023 | 22 | 2023 |
Osteopontin expression is an independent factor for poor survival in oral squamous cell carcinoma: a computer‐assisted analysis on TMA sections M Avirović, K Matušan‐Ilijaš, G Damante, D Fabrro, R Cerović, M Juretić, ... Journal of oral pathology & medicine 42 (8), 620-626, 2013 | 15 | 2013 |
Nuclear EGFR expression is associated with poor survival in laryngeal carcinoma B Marijić, T Braut, E Babarović, M Krstulja, D Maržić, M Avirović, ... Applied immunohistochemistry & molecular morphology 29 (8), 576-584, 2021 | 13 | 2021 |
The expression of calpain-1 and androgen receptor in breast cancer and their correlation with clinicopathological characteristics: An immunohistochemical retrospective study K Rajković-Molek, E Mustać, M Avirović, P Georgev, M Demaria, J Aničić, ... Pathology-Research and Practice 216 (9), 153068, 2020 | 9 | 2020 |
IMP3 protein overexpression is linked to unfavorable outcome in laryngeal squamous cell carcinoma D Maržić, B Marijić, T Braut, S Janik, M Avirović, I Hadžisejdić, F Tudor, ... Cancers 13 (17), 4306, 2021 | 8 | 2021 |
Impact of HER2 receptor status on axillary nodal burden in patients with non-luminal A invasive ductal breast carcinoma D Kustić, I Lovasić, Franjo, Belac-Lovasić, M Avirović, ... Revista medica de Chile 147 (5), 557-567, 2019 | 7 | 2019 |
Smjernice Hrvatskoga onkološkog društva za dijagnozu, liječenje i praćenje bolesnica/ka oboljelih od invazivnog raka dojke (HOD RD-3) I Belac Lovasić, M Bašić Koretić, P Podolski, N Dedić Plavetić, T Silovski, ... Liječnički vjesnik 144 (9-10), 295-305, 2022 | 6 | 2022 |
Clinical impact of sentinel lymph node biopsy after neoadjuvant systemic treatment in luminal B, HER-2 positive and triple-negative breast cancer patients with initially … A Car Peterko, M Avirović, D Mance, P Valković Zujić, I Belac Lovasić, ... Libri oncologici: Croatian journal of oncology 47 (1), 29-39, 2019 | 6 | 2019 |
The expression of ribonuclear protein IMP3 in laryngeal carcinogenesis D Maržić, M Čoklo, B Marijić, I Hadžisejdić, A Dekanić, M Krstulja, T Šepić, ... Pathology-Research and Practice 216 (6), 152974, 2020 | 5 | 2020 |
HSP70 In triple negative breast cancer: Prognostic value and clinical significance AC Peterko, K Rajković-Molek, T Gulić, DV Vujaklija, IB Lovasić, F Lovasić, ... Pathology-Research and Practice 238, 154127, 2022 | 3 | 2022 |
Two lymphoma histotypes and papillary thyroid carcinoma coexisting on Hashimoto ground: a case report and review of the literature I Iskra, MI Tomaš, TB Crnčić, E Kukić, I Hadžisejdić, M Avirović, N Girotto Diagnostic Pathology 19 (1), 52, 2024 | 2 | 2024 |
Clinical guidelines for diagnosis, treatment and monitoring of patients with invasive breast cancer–Croatian Oncology Society (BC-3 COS) I Belac Lovasić, M Bašić Koretić, P Podolski, N Dedić Plavetić, T Silovski, ... Liječnički vjesnik 144 (9-10), 295-305, 2022 | 2 | 2022 |
Utjecaj pandemije COVID-19 na rad patologije i citologije u Kliničkom bolničkom centru Rijeka D Vrdoljak Mozetič, A Savić Vuković, M Avirović, I Seili Bekafigo, ... Liječnički vjesnik 143 (3-4), 81-89, 2021 | 2 | 2021 |
Clinical Impact of Sentinel Lymph Node Biopsy after Neoadjuvant Treatment in Breast Cancer Patients with Initially Involved Axillary Lymph Nodes (Single-Center Experience) AC Peterko, M Avirović, D Mance, PV Zujić, IB Lovasić, F Lovasić European Journal of Surgical Oncology 46 (2), e38-e39, 2020 | 2 | 2020 |
Podudarnost procijenjene veličine rezidualnog tumorskog procesa magnetskom rezonancijom i patohistološkom dijagnostikom u pacijentica s karcinomom dojke nakon provedene … E Černeka, P Valković Zujić, D Grebić, M Avirović, D Miletić Medicina Fluminensis: Medicina Fluminensis 56 (2), 147-156, 2020 | 2 | 2020 |
Non-enhancing malignant lesions of the breast: A case report and review of literature PV Zujic, T Solocki-Matic, K Klaric, M Avirovic Heliyon 9 (3), 2023 | 1 | 2023 |
Differences in tolerogenic status of NK cells between luminal A type, luminal B type, and triple-negative breast cancer. A Starčević, D Grebić, M Avirović, M Mavrinac, PV Zujić, DV Vujaklija, ... Neoplasma 69 (6), 2022 | 1 | 2022 |